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The resistance to facultative intracellular bacteria such as Listeria monocytogenes or 
Mycobacterium  tuberculosis involves the interaction of lymphocytes and mononuclear 
phagocytes (1). In the course of an infection with Listeria, lymphoid cells are found in 
the spleen and thoracic duct lymph with the capacity to transfer protective immunity 
to normal mice challenged with a lethal dose of the organism (2). The protective im- 
munity involves the participation of highly microbicidal phagocytes at the sites of 
Listeria infection, almost certainly activated by the interaction of the lymphoid cells 
and the Listeria  organism or its products.  The  functional characteristics of  these 
"activated macrophages" have recently been reviewed (1) and are not the subject of 
this report. 
The resistance to L. monocytogenes is a form of cell-mediated immunity. Immunity 
to Listeria correlates well with the development of skin sensitivity to Listeria extracts 
and, of more importance, cannot be transferred with antibody, but only with lymphoid 
cells (2). Other accepted types of cell-mediated immune reactions such as skin sensiti- 
zation to products of tubercule bacillus (3), allograft rejection (4), tumor rejection (5), 
and some autoimmune states (6) are transferred to normal recipients by live cells and 
not by conventional serum antibody. The cells involved in all of these cell-mediated 
immune reactions are believed to derive from the thymus and to form part of  the 
thymus (T)  celP population of peripheral lymphoid organs.  (We accept the nomen- 
clature of T lymphocytes as those cells derived from the thymus, and B lymphocytes 
as those derived from bursa or the mammalian equivalent.) The evidence for T lym- 
phocytes being involved in cell-mediated immunities is in part  circumstantial and 
based upon the observations that such immune states are highly dependent upon an 
intact thymic function (7). Also, the fact that these immune states are not transferred 
by antibodies, a B cell product, speaks in favor of T lymphocytes as one of the effector 
cells. Recently the availability of antibodies to membrane antigens of T or B lympho- 
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cytes has permitted the direct investigation of the type of cells involved in different 
immune states  (8).  It was possible to demonstrate  with the use of antibodies to the 
thymic alloantigen 0 that indeed T  cells were involved in the killing of tumor cells (9), 
in helper function (10),  and in resistance to some viral infections (11). 
If  the  cellular  resistance  to  facultative  intracellular  bacteria  such  as  Lis- 
teria monocytogenes  is  dependent  upon  an  intact  thymic  function,  then  it  is 
expected  that  such  resistance  should  be transferable  to  normal  hosts  only by 
cell  suspensions  containing  T  lymphocytes.  We  have  investigated  this  point 
and found such expectation to be true. 
Materials and Methods 
Animals.--For all experiments involving Listeria 8-10-wk-old BC3FI male or female mice 
obtained from Cumberland Farms  (Nashville, Tenn.) were used. AKR and CBA mice were 
obtained from Jackson Laboratory, Bar Harbor, Maine. 
Microorganisms.--Listeria monocytogenes, obtained from  Dr. G.  B.  Mackaness  (Tmdeau 
Institute, Saranac Lake, N. Y.), was used in all experiments. The organism was maintained by 
serial passage in BC3F1  mice. For passage approximately 200 organisms were injected intra- 
venously (IV) into each mouse and 2 or 3 days later the spleen was homogenized in  tryptic 
soy broth (Difco Laboratories,  Detroit,  Mich.)  and  cultured  at 37°C.  The organisms were 
harvested in the log phase of their growth curve, at 16 hr, washed twice in phosphate-buffered 
saline  (PBS),  counted,  and  immediately injected into  mice for  repassing  or experimental 
studies. 
Counting Microorganisms.--The number  of organisms was  estimated  by optical density 
measurements in a Zeiss spectrophotometer (Carl Zeiss, Inc., New York) at 540 X. The readings 
were verified after appropriate dilution and 24 hr of culture in tryptose agar at 37°C in room 
air. We found that the number of viable organisms correlated reasonably with the  number 
estimated by spectrophotometry. 
L950 .--The LI)50 was determined approximately every 2 months since the virulence of the 
Listeria increased with repassing.  At the time of the transfer experiments the LDs0 was 1 X  10  ~ 
Listeria organisms. 
Immunization.--Approximately one-fifth the u)5o dose was given IV for maximal primary 
immunization. Hyperimmunization was achieved by giving approximately five times the L9 50 
dose IV 10 days after the primary immunization. 
Assay for Protective Anti-Microbial Immunity.--Anti-microbial immunity was determined 
by estimating the growth of a challenge dose of Listeria in the spleen of actively or passively 
immunized mice. The rationale for this approach is based upon the clear studies of Mackaness 
and his group with the same type of organism (1, 2). The challenge dose which was 100%'lethal 
in unimmunized animals was about five times the LDS0. 
Each experimental group usually contained six mice. The spleens were assayed 2 or 3 days 
after the IV challenge with Listeria. Each spleen was taken with sterile technique, homogenized 
in tryptic soy broth, and appropriately diluted (102, 104, and 105). Each dilution was cultured 
in duplicate in tryptose agar at 37°C in room air for 24 hr. The duplicate colony counts were 
made and averaged to express the individual spleen count. The value for each experimental 
and control group is represented by the geometric mean of that group and statistical  signifi- 
cance is measured by the Student's t test. 
Transfer of Immune Lymphocytes.--Normal, immune, and hyperimmune spleen cells were 
obtained by teasing in Eagle's minimal essential medium (Associated Biomedic Systems, Inc., 
Buffalo, N.Y.) and 5% fetal calf serum (FCS). The cells were washed two times in the same 
medium, passed through a nylon filter, and counted. Viability was estimated by trypan blue 1106  T  LYMPHOCYTES  AND  LISTERIOSIS 
dye exclusion. All cell counts were expressed as the number of viable nucleated cells. The cells 
were transferred to syngeneic recipients IV in 0.4 ml of Eagle's medium containing the chal- 
lenge dose of approximately 5 X  105 [. monocytogenes. The transfer of immunity was assayed 
in the recipient animals by the quantitative spleen colony count assay described above. 
Anti-O Serum.--Anti-O serum was produced in AKR mice (6 wk of age at the start of the 
experiment) immunized with CBA thymus cells. The AKR mice were immunized three times 
every 2  wk with  10  s thymus cells injected intraperitoneally. The first injection  contained 
besides the CBA thymocytes,  109 dead Bordetdla pertussis  organisms.  (The addition of B. 
pertussis serves as an adjuvant and increases the titer of anti-0 antibodies; we thank Dr. J. C 
Cerottini, Swiss Institute for Cancer Research, Lausanne, Switzerland, for advising us on this 
procedure.)  The anti-0 serum reacted specifically with T  cells.  The  antisera killed  96-100% 
of  thymus cells and only 30-35~,~ of spleen cells.  The spleen cells  that were spared by  the 
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FI6. i.  Growth curve of L. monocytogenes in BC3F1 mice. 8 )< 104 Listerla organisms were 
given IV to BCsF1 mice at the beginning of the experiment. Spleens of six mice were harvested 
at 1 hr, 1, 2, 3, and 6 days. Each point represents the geometric mean of the logl0 organisms 
viable in the spleens. 
treatment with anti-0 sera contained surface Ig by immunofluorescence and were  considered 
to be B lymphocytes. The complement source was guinea pig sera obtained lyophilized from 
Microbiological Associates, Inc., Bethesda, Md. The cytotoxic tests included the trypan blue 
exclusion test and the 51Cr release from cells. 
The cells,  1.5 X  10  s, were treated with 0.5 ml of sterile anti~ serum, at 37°C  for 30 min 
in a  2  ml volume. The cells were washed, resuspended in 3  ml of media containing 0.5 ml 
guinea pig sera and 0.5 mg of DNAse for 1/22 hr at 37°C.  The cells were then washed  twice, 
counted, and tested for viability. Usually 40-50% of the cells were recovered with a viability 
of 95-98(~. 
EXPERISfENTS  AND  RESULTS 
Immunity  to Listeria in BC~F1  mice.--The  immune  response  of  BC3F1  mice 
to Listeria  was  studied  by measurement  of  the growth  curve  of  the organism 
in  vivo.  8-wk-old  BC3F1  mice  received  8  >(  104  Listeria  organisms  IV.  At ~'.  C.  LANE  AND  E.  R.  UNANUE  1107 
1 hr,  1, 2, 3, and 6 days, six mice were sacrificed, and the number of Listeria 
present in the spleen determined by the spleen colony count assay. Each value 
represented the geometric mean of six animals. Results are depicted in Fig. 1. 
The rapid growth of organisms reached a  peak at 2 days and by the third 
day there was already some evidence of protective immunity since the number 
of organisms was reduced to 20 % of the 2 day peak value. For this reason, the 
second or third days were selected as the time for assay in the experiments of 
adoptive transfer of immunity. By 6 days the number of organisms was about 
1/1000 of that found at 2 days. 
The development of protective imnmnity appeared to be dependent on the 
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FIG. 2.  Development of resistance to lethal challenge of Listeria. Mice were given 8 )<  103, 
8  X  104, or 8  )<  105 Listeria IV. These mice and a group of normal mice were challenged 7 
days later with 3.64  )<  106 Listeria IV. Spleen culture and colony count assay was done 2 days 
later and the geometric mean of the six mice in each group is shown in the bar graph above. 
strength of the immunizing dose. This was  tested in an experiment in which 
BCaFI mice received no organisms, 8  X  10  a, 8  X  104, or 8  X  105 Listeria  or- 
ganisms IV. 7 days later each group of mice was challenged with 3.64  X  106 
organisms and 2 days later a spleen colony count assay was done. The points 
in Fig. 2 represent the geometric mean values of the six animals in each group. 
The 8 X  104 and 8 X  105 doses evoked similar degrees of immunity which were 
approximately 4 log10 differences from control or unimmunized animals chal- 
lenged with the same number of organisms. The administration of 8 X  10  a or- 
ganisms did not produce any resistance in the test animals. 
Transfer  of Protective Immunity.--The  adoptive transfer of protective im- 
munity to Listeria  was  achieved by the  transfer of spleen cells 7 days after 
the  primary  immunization  (immune  cells).  Spleen  cells  were  also  obtained 1108  T  LYMPHOCYTES  AND  LISTERIOSIS 
from mice which had  received a  primary immunizing dose of 1/5 L950 Listeria 
and  10 days later  a  second dose  of 5  X  LD~0. These  cells were  transferred  4 
days after the second injection (hyperimmune cells). 
Normal,  immune,  and  hyperimmune  BCaF1  spleen  cells  were  harvested  as 
described in the Materials and Methods section and transferred into syngeneic 
BCaF1  mice of the  same sex,  IV,  together  with  a  challenge dose of 5  X  LDs0 
of L.  monocytogenes. The  transfer  of immunity was  assayed  in  the  recipient 
by the quantitative spleen colony count assay described previously. 
The results,  in Fig. 3,  showed that 2  X  l0  s immune spleen cells adoptively 
transferred  immunity to syngeneic recipient mice challenged with 9  X  10  ~ L. 
monocytogenes.  (Some  degree  of  resistance  could  be  achieved  by transferring 
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FIG. 3.  Adoptive transfer  of resistance to lethal challenge of Listeria. Either 1 X  l0  s or 
2 X  108 immune spleen cells were transferred  into normal syngeneic recipients. At the same 
time these animals as well as a control group which received no cells were challenged with 
9 X  10  ~ Listeria IV. Spleen colony count assay was done 2 days later and each group of six 
mice is represented by the geometric mean. 
1 X  108 immune cells but a dose of 4  X  10  r ceils was ineffective.) As shown in 
the experiments of Fig. 4, a comparable degree of immunity could be transferred 
with 4  X  10  r hyperimmune  spleen  cells.  This apparent  expansion  of the  spe- 
cifically  committed  lymphocyte  population  in  the  hyperimmune  state  was 
evidently limited:  the  transfer  of 8  X  108 hyperimmune cells failed to confer 
protective immunity to the recipients. 
Immune spleen  cells  did  not transfer  resistance  into X-irradiated  mice.  In 
one experiment all mice that were irradiated with 660 R  and received immune 
spleen  cells  and  Listeria  organisms  died  2-3  days  later.  Hence,  as  expected 
the host mononuclear ceils were necessary for the transfer of resistance  (1, 2). 
Inhibition  of Adoptive Transfer with Anti-O Serum.--Spleen cells from hyper- 
immunized  mice were  teased,  filtered  through  nylon,  and  washed  in  Eagle's F.  C.  LANE  AND  E.  R.  UNANUE  1109 
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FIG. 4.  Enhancement of adoptive transfer by hyperimmunization. 2  >  10  s normal spleen 
cells, 2  X  10  s immune spleen cells, 4  X  10  7 hyperimmune spleen cells, and 8  X  10 6 hyper- 
immune cells were transferred IV with 9  X  10  5 Listeria organisms to normal syngeneic recipi- 
ents. 2  days later spleen colony count assay of the six mice in each group was done and the 
geometric mean values are represented by the bar graph. 
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Fro. 5.  Inhibition of adoptive transfer of Listeria resistance by anti-0 serum, l0  s hyper- 
immune spleen cells either untreated, treated with anti-0 serum, or treated with NMS as de- 
scribed in the Materials and Methods section were transferred IV with 4.75  X  105 Listeria. A 
control group received 4.75  X  l0 s Listeria but no cells. Spleen culture and colony count assay 
of the six mice in each group was performed 3 days later. The bar graph represents the geo- 
metric mean of each group. 1110  T  LYMPttOC~_'TES  AND  LISTERIOS[S 
medium with 5 % FCS. The ceils were treated with anti-0 sera, normal mouse 
serum, or not treated at all;  1  X  10  s viable cells  were injected IV in 0.4 ml 
together with the challenge dose of 4.75  X  l05 Listeria.  One group of normal 
mice received a  challenge injection of Listeria  but no cells were transferred. 
Spleen colony count assay was performed 3 days later. 
The results, described in Fig. 5, show that hyperimmune spleen cells trans- 
ferred 6 log10 degrees of protection against  a  lethal Listeria  challenge. Treat- 
ment of the hyperimmune cells  with  anti-0  serum completely abolished this 
protective effect,  but  treatment  with  normal  mouse  serum  (NMS)  had  no 
inhibitory effect. Two other experiments of this nature using immune spleen 
cells gave similar results. 
DISCUSSION 
The complete abolition of the transfer of cellular immunity by treatment of 
the lymphocytes with specific anti-0 serum indicates that T  cells are of prime 
importance in the initiation of the immune resistance to listeriosis. The speci- 
ficity of the anti-0 sera for T  cells is reasonably clear. The 0 antigen is present 
on most thymic cells and on most T  cells of peripheral lymphoid organs (8). 
All evidence implies that such 0-bearing cells are T  lymphocytes, although the 
converse has not been clearly established. Our antisera, at the doses and under 
the  technical conditions employed,  were  reacting mainly,  if not  completely, 
with T  lymphocytes and spared most, if not all,  B  lymphocytes. It then was 
apparent that a cell suspension composed mostly of B lymphocytes as a result 
of treatment  with  anti-0  sera  was  ineffective in  conferring resistance  to  lis- 
teriosis. 
One  function  of  T  lymphocytes,  that  of  killing  tumor  cells,  takes  place 
directly without the apparent intervention of any other type of lymphocyte 
(9). A second function of T  lymphocytes, that of helping in the production of 
antibody to certain antigens,  takes  place by regulation of the  activity of B 
lymphocytes  (10).  Mediating  resistance  to  infection  with  the  intracellular 
facultative bacteria L. monocylogenes is one more function of the T  cell. This 
third function takes place by attracting and stimulating the microbicidal ac- 
tivity of the mononuclear phagocyte system in some way (11). It remains to 
be  shown  whether  the  T  lymphocytes are  capable  of  elaborating  humoral 
factors which call for and  activate the macrophages and/or whether they do 
this indirectly by first acting on an intermediate B  lymphocyte. The former 
possibility is most likely; the association of delayed hypersensitivity, or cell- 
mediated  immunity,  with  mononuclear phagocytes is  well  established  (12). 
Our results bring one more piece of evidence, this time by a direct approach, 
in support of the T  cell origin of these reactions. 
Our studies do not yield information on the characteristics of the T  lympho- 
cytes except that they indicate that these cells result from antigen stimulation 
and that  thev increase in activity after secondary immunization. Mackaness F.  C.  LANE AND E.  R.  UNANUE  IIii 
and  colleagues  have  shown  that  the  lymphocytes  responsible  for  Listeria 
resistance are sensitive  to anti-lymphocyte serum (13),  appear in the thoracic 
duct early after stimulation,  do not recirculate from blood to lymph (14), and 
tend to accumulate in sites of specific or nonspecific inflammation  (15). These 
results  may be  characteristics  of T  lymphocytes which m~y show functional 
heterogeneity  during  their  life-span.  Indeed,  T  lymphocytes  with  different 
properties  have  been  identified  (16). 
SUMMARY 
Spleen  cells  of  mice  infected  with  Listeria  monocytogenes  were  adoptively 
transferred  to normal mice. Such lymphocytes conferred resistance  to a lethal 
challenge with Listeria. Hyperimmunization of the donor reduces the number 
of cells necessary to transfer effective immunity. Such spleen cells if treated  with 
anti-0 serum do not transfer resistance to Listeria. Hence, thymus (T) lympho- 
cytes are involved in the resistance to infection with the facultative intracellular 
bacteria L. monocytogenes. 
The advice of Dr. Baruj Benacerraf is appreciated. We thank Miss Ethel Gordon for valu- 
able technical assistance. 
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